baber/WOPTO huggingface dataset:
Patent NZ-589169-A (NZ)
Title: 2-phenyl-4-cyclopropyl-pyrimidine derivatives
Inventor: CAROFF EVA
IPC: A61K31/506
Filed: 2009-04-09
Abstract: The disclosure relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives of formula (I), wherein R1 represents phenyl optionally substituted once by halogen, methyl, methoxy, trifluoromethyl or trifluoromethoxy; and R2 represents hydrogen, hydroxymethyl or alkoxymethyl. These compounds of formula (I) are suitable for use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
Patent NZ-594670-A (NZ)
Title: Coffee bean packaging cartridge and coffee beverage system including same
Inventor: VAN OS IVO
IPC: A47J31/40
Filed: 2010-02-17
Abstract: 594670 A coffee beverage system 1, including a coffee bean packaging cartridge 3 and a coffee brewing apparatus 2, where the coffee bean packaging cartridge 3 is arranged for holding and supplying multiple servings of coffee beans. The cartridge 3 includes a container having an outer wall defining an interior volume and at least one exit opening 11 defining a coffee bean outlet, the container holding at least one serving of coffee beans, conveyor means 23 adapted to be rotatably driven exteriorly of the cartridge 3 for transporting the coffee beans towards the exit opening 11of the cartridge 3, and coupling means 171 adapted for drivingly coupling the conveyor means 23 to rotating motive means of a coffee brewing apparatus 2. The cartridge 3 is openable to reveal the exit opening, and is removably connected to the coffee brewing apparatus 2. The coffee brewing apparatus 2 comprises a motive means 40 for drivingly engaging the coupling means 171 of the coffee bean packaging cartridge 3 in its connected state for driving the conveyor means for transporting coffee beans from the cartridge 3 via its exit opening 11into the coffee brewing apparatus 2. The coffee brewing apparatus 2 further comprises a control unit for controlling the motive means. The dosed amount of coffee for one serving is determined by a complete fill of a fixed or adjustable volume of a dosing chamber, and part of the dosing volume is accommodated in a cavity of the coffee bean packaging cartridge 3 and another part of the dosing volume is accommodated in a dosing chamber within the coffee brewing appliance.
Patent NZ-595213-A (NZ)
Title: Electrolytic cell and method of use thereof
Inventor: MCALISTER ROY E
IPC: F24S23/71
Filed: 2010-02-17
Abstract: 595213 An electrolytic cell (2) comprising: a containment vessel (4); a first electrode (8); a second electrode (4); an electrolyte in fluid communication with the first electrode and the second electrode; a source of electrical current (32) in electrical communication with the first electrode and the second electrode to produce electrolysis, wherein a gas is formed during electrolysis at or near the first electrode; a gas extraction area; and a separator (10) comprising a substantially continuous helical configuration having two inclined surfaces forming a “V” shape. The “V” shape of the separator directs flow of the electrolyte and the gas due to a difference between density of the electrolyte and the combined density of the electrolyte and the gas such that the gas substantially flows in a direction distal to the second electrode. The helical configuration of the separator is configured to promote circulation of the electrolyte between the first electrode, the gas extraction area, and the second electrode to provide fresh electrolyte to the first electrode and the second electrode.
Patent NZ-596594-A (NZ)
Title: Stabilized micronised particles
Inventor: VAN HEE PIM
IPC: A01N43/90
Filed: 2008-03-14
Abstract: 596594 The present disclosure relates to a method for particle size reduction, in particular to a method for particle size reduction of Natamycin. Disclosed are: A method for preparing a suspension of natamycin particles having a mean particle size of 1 micrometre or less, preferably 0.5 micrometre or less and more preferably 0.2 micrometre or less, said suspension being stable in the absence of a stabilizer, the method comprising the step of subjecting natamycin to wet grinding at a pH of 4.6 or lower or at a pH of 6.7 or higher, Natamycin particles having a mean particle size of 1 µm or less or 0.5 µm or less or 0.2 µm or less, A suspension comprising natamycin pafticles, A method for producing a concentrated suspension, a paste, a powder, a film, a coating or a foil comprising natamycin particles, A concentrated suspension, a paste, a powder, a film, a coating or a foil, use of the disclosed products for the production of products of the food orfeed industry, horticulture, agriculture or pharmaceutical industry, A food product, feed product, horticultural product, agricultural product or pharmaceutical product comprising one of the procucts disclosed herein.
Patent NZ-596639-A (NZ)
Title: Use of lcat for treating anemia and red blood cell dysfunction
Inventor: AUERBACH BRUCE
IPC: A61K38/45
Filed: 2010-06-14
Abstract: NZ 596639 Disclosed is the use of the enzyme lecithin:cholesterol acelytransferase (LCAT) in the manufacture of a medicament for treating anaemia or red blood cell dysfunction in a patient having a condition characterised by anaemia or red blood cell dysfunction wherein the condition is selected from the group consisting of sickle cell disease, diabetes, thalassemia, rheumatoid disease, an autoimmune disease, arthritis, a liver disease, cirrhosis, hepatitis, acanthosytosis, sepsis, dementia, or a microvascular disorder, an inflammatory disorder, parasitic disease, erectile dysfunction, cancer, pre-eclampsia, critical illness, and trauma.
Patent NZ-599059-A (NZ)
Title: Pcsk9 vaccine
Inventor: CHAMPION BRIAN ROBERT
IPC: A61K38/08
Filed: 2010-08-23
Abstract: NZ 599059 Disclosed is an immunogen comprising at least one antigenic proprotein convertase subtilisin-kexin type 9 (PCSK9) peptide, or a functionally active variant thereof, linked to an immunogenic carrier, wherein the antigenic PCSK9 peptide consists of an amino acid sequence selected from the group consisting of SEQ ID NOs 182-188,317, and 401-403, as defined in the complete specification.
Patent NZ-601074-A (NZ)
Title: Synergistic herbicidal composition containing aminopyralid and 2,4-dichlorophenoxyacetic acid
Inventor: CARRANZA GARZON NELSON
IPC: A01P13/00
Filed: 2011-01-27
Abstract: An herbicidal composition containing (a) aminopyralid as an ester or a salt and (b) 2,4-D provides synergistic control of selected broadleaf weeds. The composition may be used in control of undesirable vegetation particularly in rice.
Patent NZ-602625-A (NZ)
Title: Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and a nmda-antagonist for the treatment of pain
Inventor: BLOMS-FUNKE PETRA
IPC: A61K31/13
Filed: 2011-06-14
Abstract: 602625 Disclosed is a combination comprising as component(s): (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol of formula (I) (such as tapentadol), optionally in the form of one of its stereoisomers, a racemate or in the form of a mixture of its stereoisomers in any mixing ratio, or any corresponding acid addition salt thereof, and (b) at least one NMDA-antagonist selected from the group consisting of (R,S) ketamine, (S)-ketamine and memantine. Further disclosed is a pharmaceutical composition comprising a combination comprising (a) tapentadol hydrochloride; and b ketamine or memantine; which is formulated for oral, intravenous, intraarterial, intraperitoneal, intradermal, transdermal, intrathekal, intramuscular, intranasal, transmucosal, subcutaneous, or rectal administration for use in the treatment of pain selected from inflammatory pain, neuropathic pain, acute pain, chronic pain, visceral pain, migraine pain and cancer pain.
Patent NZ-603018-A (NZ)
Title: Delayed coking process
Inventor: CATALA KENNETH A
IPC: C10B55/00
Filed: 2011-04-08
Abstract: A delayed coking heater 10 for heating a feedstock to delayed coking temperature comprises a heater including a radiant heating zone 14 comprising a lower portion including a hearth burner section and an upper portion including a wall burner section. The hearth burner section comprises a plurality of hearth burners 46 located adjacent to the bottom hearth for firing in the radiant heating zone 14. The wall burner section comprises a plurality of wall burners located adjacent to opposing walls. A vertical serpentine heating coil 26 is located in the radiant heating zone. The heating coil 26 includes multiple parallel horizontally extending flow conduits, that define a continuous flow path extending from at least one inlet disposed in an upper portion of the radiant heating zone of the heater to at least one outlet disposed in a lower portion of the radiant heating zone of the heater.
Patent NZ-608652-A (NZ)
Title: Power lift lumbar support system
Inventor: LAPOINTE LARRY P
IPC: A47C7/46
Filed: 2011-08-11
Abstract: Disclosed is a power lift lumbar support system for a furniture member. The power lift lumbar support system allows the occupant to adjust a lumbar support without rotation of the seat back. The support system comprises a lumbar pad (64); a scissoring portion (66); a lumbar actuation portion (68) and a linkage set (77). The scissoring portion (66) is rotatably connected to the lumbar pad (64) to move the lumbar pad (64) between a fully retracted and a fully extended position. The lumbar actuation portion (68) is connected to the scissoring portion (66) and drives the scissoring portion using a powered actuator (78) to displace the lumbar pad (64) when the powered actuator (78) is actuated. The linkage set (77) connects the lumbar actuation portion (68) to the scissoring portion (77). The linkage set (77) includes a link which is rotatably connected to the lumbar actuation portion (68). The link operates to displace a first (110) and second (112) carrier displacement link to displace the scissoring portion (66).
Patent NZ-610714-A (NZ)
Title: Inoculator and antibody for computer security
Inventor: HOGLUND MICHAEL G
IPC: G06F21/57
Filed: 2011-10-31
Abstract: A method of providing security to a computer and an apparatus are disclosed. The apparatus comprises means for determining, in a computer, a location where an undesired computer program is configured to reside upon installation on the computer; and means for providing, to the computer, a data object to occupy the determined installation location of the undesired computer program in the computer to prevent the undesired computer program from being installed in the determined installation location on the computer. The means for determining and the means for providing are component parts of an inoculator engine. The inoculator engine can be configured to provide a null configuration object in a second location in the computer with the null configuration object is associated with the data object. The null configuration object can comprise a null registry key or a null configuration information. The location can comprise a memory space or a file system location. The data object can have the same name as the undesired computer program.
Patent NZ-617930-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23L33/00
Filed: 2009-04-28
Abstract: The disclosure relates to a method comprising: electron beam irradiating a biomass material comprising a genetically modified corn or soybean which has been irradiated with a radiation dose of between 10 Mrad and about 150 Mrad; and producing a sugar by the saccharification of the electron beam irradiated biomass material. The sugar may be selected from the group consisting of glucose, xylose, arabinose, mannose, and galactose.
Patent NZ-619942-A (NZ)
Title: Leukotoxin e/d as a new anti-inflammatory agent and microbicide
Inventor: TORRES VICTOR J
IPC: A61K38/16
Filed: 2012-06-19
Abstract: Discloses use of a CCR5 antagonist in the manufacture of a medicament for the treatment of an infection caused by a lukE/D+ strain of Staphylococcus aureus in a subject.
Patent NZ-620785-A (NZ)
Title: Aptamer bio-sensor and methods to detect small molecules in a sample
Inventor: OMAR AHMED H ALSAGER
IPC: G01N33/543
Filed: 2014-02-05
Abstract: A method for the detection of small molecules in a sample comprises a) coupling a nanoparticle (NP) or microparticle (MP) to an aptamer specific for the small molecule to be detected to form a NP-aptamer conjugate; b) contacting the NP-aptamer conjugate with the sample; and c) detecting a reduction in the size, a change in surface potential, or a change in mobility of the NP-aptamer conjugate. The reduction or change is indicative of the presence of the small molecule. A biosensor comprising (a) a nanoparticle or microparticle and (b) an aptamer useful in the detection of a small molecule in a sample is disclosed. The nanoparticle or microparticle is coupled to the aptamer to provide an NP-aptamer conjugate, and where there is a reduction in the size, a change in surface potential, and/or a change in mobility of the NP-aptamer conjugate when the NP-aptamer conjugate is contacted with a small molecule in a sample. Also disclosed is an aptamer having a sequence as defined in the specification.
Patent NZ-623804-A (NZ)
Title: Stretch sensor device
Inventor: SIMONSEN OLE
IPC: A61B5/11
Filed: 2012-09-11
Abstract: Disclosed is a sensor device configured to process stretch data for determining a stretch value of a body part. The sensor device comprises a stretch sensor directly connected to the body part for obtaining stretch data (100). The stretch sensor is a capacitive or resistive sensor, which changes its capacitance or resistance as a function of elongation. The sensor device is configured to process stretch data from the stretch sensor for determining a stretch value of the body part. The sensor device comprises a processor configured for analysing the stretch data while the body part is in motion; and analysing the stretch data to identify portions (104) of the cyclic stretch data (100) which correspond to motions of the body part. The portions (104) of the stretch data are identified so that the portions (104) contain first and second stretch data points (101, 102) associated with respective first and second motion-phases of the body part. The sensor device analyses the cyclic stretch data (100) to identify first and second stretch values (101, 102) by determining minimum and maximum sensor values (121,122). The sensor device further analyses the cyclic stretch data (100) to identify the portions (104) ensuring that the portions (104) contain portions of an entire period (106) of a cyclic harmonic signal containing first and second stretch data points (101, 102) associated with respective first and second motion-phases of the body part and to distinguish values related to other motion phases (143). The sensor device is also configured for analysing the identified portions (104) of stretch data (100) to determine first and second sensor values (121, 122) of the respective first and second stretch data points (101,102); and determining stretch values (103) by determining the differences between the first and second sensor values (121, 122).
Patent NZ-629047-A (NZ)
Title: A heterogeneous inseminate system
Inventor: ROSENSTEIN MAURICE A
IPC: A61K38/00
Filed: 2011-06-08
Abstract: Disclosed is a heterogeneous inseminate, comprising: a) a first amount of sperm of a first animal; and b) a second amount of sperm of a second animal combined with the first amount of sperm of the first animal, the first animal and the second animal of the same species, wherein only one of the first amount of sperm or the second amount of sperm comprises sex selected sperm resulting from a sex selection process which separates sperm based on bearing an X- chromosome or a Y-chromosome.
Patent NZ-629367-A (NZ)
Title: Variable geometry lift fan mechanism
Inventor: LONG GEOFFREY A
IPC: B64C29/00
Filed: 2013-08-23
Abstract: An aircraft fan mechanism with multiple rotor blades or propellers on the same axis is described. The mechanism provides two configurations that are optimised for vertical thrust and hovering respectively. The mechanism includes a plurality of fans (101A, 101B) which scissor between a deployed configuration (upper drawing) and a collapsed, stowed or aligned configuration (lower drawing), the former providing greater vertical lift during takeoff and landing. The relative positioning of the helicopter blades are affected by stops including magnets, detent, spring loaded pawl and groove, or variation of the speed of a first rotor blade.
Patent NZ-631735-A (NZ)
Title: Grip for cricket bat and cricket bat handle
Inventor: AUSTIN ROBERT MOREY
Filed: 2014-09-12
Abstract: A handle of a cricket bat (10) including a grip (18) is disclosed. At least one guide (22) extends along the grip (18) generally parallel to the longitudinal axis of the handle. The guide (22) is arranged to assist in the positioning of a batsman’s hands during play. The guide is offset from the plane by a distance of 1 to 5mm bisecting the bat lengthways and passing through the spine of the bat.
Patent NZ-706275-A (NZ)
Title: Windscreen installation apparatus and method
Inventor: DAVIES CHRISTOPHER
IPC: B62D65/06
Filed: 2011-11-02
Abstract: Apparatus for use in handling windscreens is disclosed. The apparatus may be used to install windscreens in a vehicle. The apparatus includes a windscreen anchor assembly (2) comprising a windscreen anchor device and a support arm (16) extending away from the windscreen anchor device. A mount assembly (3) is provided for supporting the windscreen anchor assembly (2). The mount assembly (3) includes a mount structure (11) for engaging with the support arm (16) such that the support arm can slide bodily in its longitudinal direction with respect to the mount structure (11). Additionally, the support arm is able to be dismantled into more than one piece for stowage, the anchor device and a dismantled arm part being provided with means for attaching to one another.
Patent NZ-712194-A (NZ)
Title: Uracil derivatives as axl and c-met kinase inhibitors
Inventor: DANDU REDDEPPAREDDY
IPC: C07D491/056
Filed: 2012-11-14
Abstract: The disclosure relates to uracil derivative compounds of the general Formula I, wherein the variables are as defined in the specification. The preferred compound is 3-(4-fluorophenyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid [4-(6,7-dimethoxyquinolin-4-yloxy)-3-fluorophenyl]-amide. The compounds are AXL and c-MET inhibitors. Pharmaceutical compositions comprising these compounds may be useful in the treatment of cancer.
Patent NZ-720106-A (NZ)
Title: A process for the preparation of regadenoson
Inventor: ZHANG XIAOHENG
IPC: C07H19/167
Filed: 2013-12-10
Abstract: The present invention provides processes for the preparation of regadenoson having the formula (I). In some embodiments, the intermediates for the synthesis of regadenoson are also provided.
Patent NZ-720497-A (NZ)
Title: Prevention and treatment of toxicosis
Inventor: QUINN JANE
IPC: A61P39/00
Filed: 2014-11-20
Abstract: The invention described in this specification relates to the prevention and treatment of alkaloid-induced toxicosis in pasture grazing animals. Disclosed herein is a method of treating lolitrem B toxicity via the administration of bromides, like potassium bromide.
Patent NZ-731861-A (NZ)
Title: A screening test for detection of deep vein thrombosis
Inventor: SIMPSON LAURENCE
IPC: A61B5/11
Filed: 2015-10-15
Abstract: A system (100) for assessing a subject at risk of a soft tissue abnormality such as deep vein thrombosis (DVT), comprises a motion sensor (108) which is adapted to be fixed, in use, to a muscle (106) of the subject. The motion sensor includes a transmitter (206) configured to transmit a signal (400) representing motion of the sensor. A receiver (118) is configured to receive the signal from the transmitter of the motion sensor. A signal processor (112) is coupled to the receiver and configured to analyse first and second data sets received via the receiver from the motion sensor. The first and second data sets represent respective first and second oscillatory mechanical responses of first and second muscles of the subject resulting from mechanical stimuli. The analysis comprises determining first and second parameter sets characterising the first and second oscillatory mechanical responses, and comparing the first parameter set with the second parameter set to assess a possible presence of DVT in the subject.
Patent NZ-733563-A (NZ)
Title: An unmanned aerial vehicle for fishing
Inventor: TAO GAN
IPC: B64C39/00
Filed: 2017-07-07
Abstract: The present disclosure discloses an unmanned aerial vehicle (UAV), comprising a housing having a top part and a bottom part comprising a first sliding groove, a plurality of arms arranged on the top part, a battery unit arranged within the housing, a processor arranged within the housing, a launching unit having a slide bar and a driving component, and a supporting component arranged on the housing to support the slide bar. One end the slide bar is rotatably connected to a pivot. The other end of the slide bar is slidably connected to the supporting component. The driving component is to actuate one of the slide bar and the supporting component to separate the slide bar from the supporting component. The slide bar is to rotate about the pivot after separating from the supporting component. The pivot is slidably connected within the first sliding groove, and the driving component is to actuate the pivot to slide within the first sliding groove until a displacement of the slide bar causes separation of the slide bar from the supporting component. Embodiments of the invention may provide a UAV which is readily configured for fishing and which provides for efficient bait or fishhook deployment in flight.
Patent NZ-749820-A (NZ)
Title: Anti-tim-3 antibodies
Inventor: CARPENITO CARMINE
IPC: A61P35/00
Filed: 2017-08-17
Abstract: The present disclosure relates to antibodies that bind human T-cell immunoglobulin- and mucin-domain-containing protein-3 (Tim-3), and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and ionizing radiation.
Patent NZ-760205-A (NZ)
Title: Treatment of hepatocellular carcinoma characterized by hepatitis b virus infection
Inventor: FILVAROFF ELLEN
IPC: A61K31/4985
Filed: 2018-06-21
Abstract: Provided herein are methods for treating and/or preventing hepatocellular carcinoma (HCC) characterized by hepatitis B virus (HBV) infection in a patient, comprising administering an effective amount of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one or a pharmaceutically acceptable salt or tautomer thereof (collectively referred to herein as “Compound 1”) to the patient having HCC characterized by HBV infection.
Patent NZ-761019-A (NZ)
Title: Method and apparatus for pasteurizing and dehydrating marijuana
Inventor: DURANCE TIMOTHY D
IPC: A61L2/12
Filed: 2017-08-30
Abstract: A method and apparatus for pasteurizing and drying marijuana plant materials using a microwave-vacuum chamber. The pasteurizing and drying are carried out with no use of ionizing radiation and with rapid drying. Pasteurization is done at a temperature and for a time period that are sufficient to reduce microorganisms to an acceptably low level, while not significantly reducing the psychoactive compounds in the material. In the process, the pressure inside a vacuum chamber is reduced to a first pressure less than atmospheric. The material is maintained in the vacuum chamber at the first pressure at a pasteurizing temperature while irradiating the material with microwave radiation. The pressure is then reduced to a second pressure lower than the first pressure and the material is maintained in the vacuum chamber at the second pressure for a time period at a dehydrating temperature lower than the pasteurizing temperature while irradiating the material with microwave radiation. The pasteurizing and dehydrating steps can be done in the reverse order.